The Top 10 Hidden Champions in the Digital Cardiology Market on R2GConnect

The digital cardiology market is transforming traditional heart health care and management with range of solutions from medical devices, wearable technologies, and platforms. R2GConnect presents the hidden champions of the digital cardiology segment from its database of over 8,200 digital health companies. Explore the watchlist candidates and connect on the R2GConnect platform.

The digital cardiology market has been evolving, fuelled by advancements in medical devices, wearable technologies, AI, and comprehensive disease management platforms. Companies are leveraging these technologies to improve patient outcomes and diagnostics and streamline clinical workflows, making significant strides in heart health management.

Eko Health, one of the leading cardiology solutions providers, closed a $41 million series D funding in June 2024, and received U.S. FDA clearance for its heart murmur and low ejection fraction detection algorithm powered by AI. AliveCor similarly received another FDA clearance for the commercial launch of its AI-powered Kardia 12L ECG System in June 2024.

Large and medium medical technology companies also started to introduce new services catering to cardiology patients and HCPs. GE Healthcare, for example, launched CardioVisio to assist clinicians in visualizing relevant data from range of sources for disease progression in atrial fibrillation patients. Royal Philips acquired BioTelemetry in 2021 and ventured into the remote cardiac diagnostics and monitoring solutions market. Withings, in January 2024, introduced a new device, BeamO, serving as an ECG, oximeter, thermometer and stethoscope device, all-in-one.

Additionally, the tech giants have also been leveraging their smart wearables and AI capabilities in managing heart health. Apple announced in May 2024 that it received FDA clearance for its atrial fibrillation detection tool on Apple Watch. Google’s Fitbit smart watches are also providing irregular heart rhythm notifications to their users.

Several pharmaceutical giants also closed partnerships with digital health companies in heart health management. Bayer announced its partnership with HUMA in February 2023, to develop Bayer Aspirin Heart Risk Assessment tool for patients’ risk assessment for developing cardiovascular disease in the next 10 years. Novartis also partnered with Dawn Health to build remote monitoring solutions for range of chronic conditions including hypertension and cardiovascular diseases.

While the renowned medical technology and digital health companies in the cardiology segment have already been under the media spotlight, the “hidden champions” of the market segment are also poised for future success.

R2GConnect, an extensive and growing digital health company repository and partnership builder platform with over 8,200 companies globally, shares this curated watchlist featuring the Top 10 hidden champions in the digital cardiology market.

Driven by AI-powered analysis of R2GConnect’s extensive database on the member companies, the Top 10 hidden champions are selected based on their services and performance across key metrics including Dynamism, Readiness to Execute, and Aspiration.

Dynamism assesses a company’s continuous growth since its inception, and its financial strength, which signals its sustainability as a stand-alone business. Companies like Rhythm Diagnostic Systems, CardioSignal by Precordior and myoncare by ONCARE in the Top 10 list demonstrated persistent resilience and robustness in their growth journey.

Readiness to Execute evaluates a company’s readiness to scale up, with comprehensive business and distribution models, experience and size of its team, and its awareness of the competitive market landscape. Wellthy Therapeutics, Powerful Medical and Vivalink as well as Cardisio show strong competence in executing business strategies.

Finally, Aspiration takes a look at the value proposition and implementation of emerging technologies and AI in the solutions, patents, pilot and clinical studies, and the addressable market sizes. Besides Wellthy Therapeutics with a high mark, most of the Top 10 hidden champions and their solutions in the digital cardiology segment garnered moderate success in the evaluation.

The Top 10 hidden champions in the digital cardiology market presented by R2Gconnect prove innovative approaches, and continuous efforts to change the way heart health is managed today. As these companies advance and strengthen their market presence, they offer compelling opportunities for stakeholders aiming to enhance digital cardiology care through strategic partnerships and investments.

To find out which company best suits your needs, summarize what you are looking for in a briefing (open call) on R2Gconnect, and tap into the digital cardiology solution providers that best fit to your request. Search for the best partners in our growing startup Radar database (8,200+ startups). Choose your hidden champion.

Get started and create your first briefing at www.R2GConnect.com or book a demo session at https://www.r2gconnect.com/r2g-demo-booking